Estimating Long Term Cost Savings from Treatment of Alzheimer??s Disease

This publication has 10 references indexed in Scilit:

• Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial Commentary: Another piece of the Alzheimer's jigsaw
  BMJ, 1999
• Economic impact of Alzheimer's disease in the United Kingdom
  The British Journal of Psychiatry, 1999
• A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease
  Neurology, 1998
• Cognitive Function and the Costs of Alzheimer Disease
  Archives of Neurology, 1997
• The Efficacy and Safety of Donepezil in Patients with Alzheimer's Disease: Results of a US Multicentre, Randomized, Double-Blind, Placebo-Controlled Trial
  Dementia and Geriatric Cognitive Disorders, 1996
• Modelling programme costs in economic evaluation
  Journal of Health Economics, 1996
• A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease. The Tacrine Study Group.
  1994
• Alzheimer's disease: the burden of the illness in England.
  1993
• A Double-Blind, Placebo-Controlled Multicenter Study of Tacrine for Alzheimer's Disease
  New England Journal of Medicine, 1992
• “Mini-mental state”
  Journal of Psychiatric Research, 1975